Loading…
Global Vitality, Inc., operating as Enzyme Process International, received an FDA Warning Letter on April 16, 2020, regarding drug products. Based on the limited metadata available, the specific violations cannot be detailed as no subject line information was provided with this record. The warning falls under FDA drug regulation authority, though the issuing office is not specified in the available metadata. A review of the complete letter would be necessary to identify the particular compliance issues cited.